Softbank Group Corp Recursion Pharmaceuticals, Inc. Transaction History
Softbank Group Corp
- $23.8 Billion
- Q2 2025
A detailed history of Softbank Group Corp transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Softbank Group Corp holds 14,667,491 shares of RXRX stock, worth $79.4 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
14,667,491
Previous 14,667,491
-0.0%
Holding current value
$79.4 Million
Previous $77.6 Million
4.35%
% of portfolio
0.31%
Previous 0.27%
Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
367Shares Held
288MCall Options Held
7.76MPut Options Held
6.19M-
Vanguard Group Inc Valley Forge, PA36.1MShares$195 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33MShares$178 Million1.38% of portfolio
-
Baillie Gifford & CO24.2MShares$131 Million0.1% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$93.6 Million0.0% of portfolio
-
Kinnevik Ab (Publ) Stockholm, V713.4MShares$72.7 Million100.0% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $976M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...